UCLA RAD ONC AT ASTRO 2024 - Flipbook - Page 6
MONDAY, SEPTEMBER 30, 2024
Monday, September 30 at 5:00PM
SESSION: S 26 - Sarcoma 1: Optimizing Treatment Outcomes in Soft
Tissue Sarcoma and Melanoma / 247 - A Phase II Trial of 5-Day
Neoadjuvant Radiation Therapy for Patients with High-Risk Primary
Soft Tissue Sarcoma: Long-Term Follow-Up and Outcomes
PRESENTER: JOHN NIKITAS, MD
LOCATION: Room 143
Monday, September 30 at 5:00PM
SESSION: PQA 06 - PQA 06 Biology and Patient Reported
Outcomes/QoL/Survivorship Poster Q&A / 2866 - Genetic Profiling of
Aggressive Prostate Cancer in Patients Undergoing High Dose Rate
(HDR) Brachytherapy
PRESENTER: BETH NEILSEN, MD, PHD
LOCATION: Hall C
Monday, September 30 at 5:00PM
SESSION: PQA 06 - PQA 06 Biology and Patient Reported
Outcomes/QoL/Survivorship Poster Q&A
2796 - Longitudinal T-Cell Receptor Analysis of Patients with Locally
Advanced NSCLC Treated with Hypofractionated Chemoradiation and
SABR Boost
PRESENTER: ISABEL GORONZY, PHD
LOCATION: Hall C